In the Summer, 1998 edition
of LIAISON, CCOHS brought to your attention a WHMIS Policy Issue Sheet regarding
ACGIH carcinogens. The tripartite WHMIS Current Issues Committee had resolved
that the Controlled Products Regulations (CPR) should be revised to include
chemicals classified as A3 (animal carcinogens) by the American Conference of
Governmental Industrial Hygienists. This change was not gazetted in the Canada
Gazette, but was published in a Current Issues Committee Policy Issue Sheet
(No. 72(b)).
As a result of the guidance
contained in this Policy Issue Sheet, followed by discussions with Health Canada,
CCOHS amended the proposed WHMIS classifications for ten chemicals in the CHEMINFO
database. Recently, Health Canada clarified that "if a controlled product
does not otherwise fall within any other Class D criteria specified in the CPR,
a supplier would not be legally obliged to depict the symbol corresponding to
Division 2 of Class D (i.e., the stylized "T") on the sole basis that
it is included in ACGIH A3. However, regarding MSDS disclosure, suppliers should
refer to WHMIS Information Bulletin No. 12 and the Product Safety Reference
Manual available from Health Canada".
Based on this clarification,
CCOHS has again reviewed the carcinogenicity data for the ten chemicals in question.
In all cases, it has been concluded that there is insufficient information to
classify these chemicals as WHMIS carcinogens. Consequently, CCOHS has revised
the affected records to remove the carcinogenicity classification. The CCOHS
CHEMINFO reviews still disclose that these chemicals have been designated A3
(animal carcinogens) by ACGIH.
The ACGIH A3 carcinogenicity
designation is specifically assigned to chemicals that are carcinogenic in animals
under conditions that may not be relevant to worker exposure (for example, at
relatively high doses or by non-relevant routes of exposure). In most cases,
assigning a carcinogenicity classification exclusively based on the A3 designation
was considered overly conservative. For additional information, consult the
CHEMINFO database records for these chemicals.
Update on Xylene and WHMIS
The WHMIS Enforcement Issues
Subcommittee consists of thirteen governmental Canadian agencies responsible
for occupational safety and health, including the administration of the WHMIS
compliance program. On behalf of this committee, Health Canada recently (January
26, 1999) issued a letter regarding MSDSs and labels for products that contain
xylene.
Several Canadian regulatory
authorities including Health Canada have concluded that xylene meets the criteria
for Section 53 (Teratogenicity and Embryotoxicity) of the Controlled Products
Regulations, resulting in a classification of D2A. This classification is based
on animal evidence of developmental toxicity that was observed in the absence
of maternal toxicity.
The Hazardous Products Act
and the Controlled Products Regulations DO NOT require the disclosure of WHMIS
class(es), division(s) nor subdivision(s) on the product label or MSDS. However,
if a supplier/importer has disclosed the WHMIS classification on the MSDS and/or
label, the WHMIS Enforcement Issues Subcommittee has stated that it is unacceptable
that the supplier/importer not also disclose D2A. Importers and suppliers of
products containing xylene have been asked to comply with this request within
90 days from January 26, 1999.
CCOHS has classified xylene
as fetotoxic based on observations of reduced weight, delayed ossification of
the skull and behavioural effects in the offspring of rats exposed by inhalation
to 500 ppm xylene. These fetotoxic effects were observed in the absence of maternal
toxicity. For additional information, consult the CHEMINFO database record for
xylene (mixed isomers).
The following chemicals are
no longer classified as WHMIS carcinogens in the CHEMINFO database:
aniline, bromoform, chlorobenzene,
chrysene*, ethyl chloride,hydrogen peroxide, hydroquinone, methyl tert-butyl
ether, 1,1,2,2,-tetrachloroethane and trichloroacetic acid.
*Even though chrysene does
not specifically meet the WHMIS carcinogenicity criteria, CCOHS scientific staff
recommend that chrysene be handled as a possible carcinogen. Chrysene seldom
occurs naturally on its own. Rather, it is part of complex mixtures of polycylic
aromatic hydrocarbons, some of which are known carcinogens.
The WHMIS Information Bulletin
Issue No. 12 can be obtained via the internet at http://www.hc-sc.gc.ca/ehp/ehd/catalogue/psb_pubs/whmis12.htm
The Product Safety Branch WHMIS
Reference Manual can be obtained by contacting WHMIS Development, Interpretation
and Compliance Section of Health Canada at Product Safety Bureau, 12th Floor,
Jeanne Mance Building, Address Locator:1912A, Tunneys Pasture, Ottawa,
Ontario K1A 0K9.